Antimicrobial Drugs: Mechanisms, Resistance, and Clinical Applications

Antimicrobial Drugs

Introduction to Antimicrobial Drugs

Antimicrobial drugs are chemical agents used to inhibit or kill microorganisms, with antibiotics being a major class produced naturally by fungi or Bacteria. Their clinical utility depends on selective toxicity, which means they target microbial cells while sparing host tissues.

• Selective toxicity: The ability of a drug to harm the pathogen without harming the host.

• Classification: Antibiotics are classified by their mechanism of action (MOA), each targeting specific bacterial structures or processes.

• Spectrum of activity: Broad-spectrum antibiotics are effective against both Gram-positive and Gram-negative bacteria, while others are more selective.

Example: Penicillins are effective mainly against Gram-positive bacteria, while tetracyclines are broad-spectrum.

Mechanisms of Action of Antimicrobial Drugs

Major Targets of Antibiotics

Antibiotics exert their effects by interfering with essential bacterial processes. The main targets include:

• Cell wall synthesis

• Protein synthesis (translation)

• Nucleic acid synthesis

• Folate metabolism

• Cytoplasmic membrane structure and function

Example: The diagram below (not shown) illustrates the cellular targets of common antibiotics, such as penicillins (cell wall), quinolones (DNA gyrase), and macrolides (protein synthesis).

Cell Wall Synthesis Inhibitors

Most antibiotics used globally are β-lactam antibiotics, which include penicillins and cephalosporins. These drugs inhibit the synthesis of peptidoglycan, an essential component of the bacterial cell wall, leading to cell lysis.

• β-lactam ring: The core chemical structure found in penicillins and cephalosporins.

• Mechanism: Inhibit transpeptidase enzymes involved in cross-linking peptidoglycan layers.

Example: Penicillin G is effective against Gram-positive bacteria but is acid-sensitive and β-lactamase sensitive.

Frequency of Antibiotic Usage

Antibiotic Class	Percentage of Use
Penicillins	40%
Cephalosporins	24%
Macrolides	12%
Quinolones	11%
Other	13%

Structures and Modifications of β-lactams

Natural Penicillin (G)	Semi-synthetic Penicillins
Gram-positive activity; β-lactamase and acid-sensitive	Methicillin: β-lactamase-resistant Oxacillin: Acid-stable, β-lactamase-resistant Ampicillin: Broader spectrum, acid-stable, β-lactamase-sensitive Carbenicillin: Broadest spectrum, acid-stable, β-lactamase-sensitive

Protein Synthesis Inhibitors

Many antibiotics inhibit bacterial protein synthesis by binding to the ribosome. Bacterial ribosomes (70S) differ from eukaryotic ribosomes (80S), allowing for selective toxicity.

• Aminoglycosides (e.g., streptomycin): Bind to 30S subunit, causing misreading of mRNA.

• Tetracyclines: Block attachment of tRNA to the ribosome.

• Macrolides (e.g., erythromycin): Bind to 50S subunit, inhibiting translocation.

Example: Erythromycin is used to treat respiratory tract infections caused by Gram-positive bacteria.

Nucleic Acid Synthesis Inhibitors

Some antibiotics target enzymes involved in DNA replication or transcription.

• Quinolones (e.g., ciprofloxacin): Inhibit DNA gyrase, preventing DNA supercoiling and replication.

• Rifamycins: Inhibit bacterial RNA polymerase, blocking transcription.

Antimicrobial Drug Resistance

Mechanisms of Resistance

Antimicrobial drug resistance is the acquired ability of a microorganism to resist the effects of a chemotherapeutic agent to which it is normally sensitive. Resistance can be intrinsic or acquired through mutation or horizontal gene transfer.

• Reduced permeability: The organism is impermeable to the antibiotic.

• Inactivation: The organism produces enzymes that inactivate the antibiotic (e.g., β-lactamases).

• Altered target: The organism modifies the antibiotic's target site.

• Resistant biochemical pathway: The organism develops an alternative pathway not affected by the drug.

• Efflux: The organism pumps the antibiotic out of the cell (efflux pumps).

Table: Bacterial Resistance to Antibiotics

Mechanism	Antibiotic Example	Genetic Basis	Microorganism Example
Reduced permeability	Penicillin	Chromosomal	Gram-negative bacteria
Inactivation of antibiotic	Penicillin, Chloramphenicol	Plasmid and chromosomal	Staphylococcus aureus, Escherichia coli
Alteration of target	Aminoglycoside, Erythromycin, Rifampin	Plasmid and chromosomal	Staphylococcus aureus, Mycobacterium tuberculosis
Development of resistant pathway	Sulfonamide	Chromosomal	Escherichia coli
Efflux (pumping out of cell)	Tetracycline, Erythromycin	Plasmid, Chromosomal	Staphylococcus aureus, Escherichia coli

Clinical Implications and New Strategies

• Antibiotic resistance is a major public health concern, leading to treatment failures and increased mortality.

• Strategies to combat resistance include the development of new antibiotics, combination therapy, and stewardship programs to limit misuse.

Example: Methicillin-resistant Staphylococcus aureus (MRSA) is resistant to all β-lactam antibiotics due to altered penicillin-binding proteins.

Additional info: Horizontal gene transfer (via plasmids, transposons, or bacteriophages) is a key mechanism by which resistance genes spread among bacterial populations.